Ciprofloxacin 250mg/5ml oral suspension
BNF presentation 0501120L0AABGBG within chapter Infections. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0501120L0AABGBG
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
2,957
NHS spend (£)
£109,760.75
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 323 |
| February 2025 | 6 |
| December 2024 | 90 |
| November 2024 | 443 |
| October 2024 | 432 |
| August 2024 | 34 |
| July 2024 | 390 |
| May 2024 | 63 |
| July 2021 | 166 |
| June 2021 | 100 |
| December 2020 | 395 |
| November 2020 | 515 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 14 | No data available |
| Unknown pharmacy | 11 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |